Skip to main content
SpringerLink
Log in

Control of Nuclear Function in Chromaffin Cells by Persistent Activation of Nicotinic Receptors

  • Chapter
Cholinergic Mechanisms and Psychopharmacology

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 24))

  • 199 Accesses

Abstract

The membrane of chromaffin cells contains nicotinic and muscarinic receptors which are innervated by cholinergic axons — the only neurites reaching the adrenal gland. Persistent activation of nicotinic receptors is associated with an increase in the 3′, 5′-cyclic adenosine monophosphate (cAMP) (19) content of adrenal medulla, whereas the stimulation of muscarinic receptors causes an increase in the 3′, 5′-cyclic guanosine monophosphate (cGMP) content (21). The data reported in Fig. 1 show that carbamylcholine, a mixed agonist of nicotinic and muscarinic receptors increases the cAMP and cGMP content of adrenal medulla. In addition, Fig. 1 shows that hexamethonium blocks the increase of cAMP but not that of cGMP elicited by carbamylcholine, In contrast, atropine blocks the increase in cGMP but not that in cAMP elicited by the cholinergic receptor agonist.

Persistent Activation of Acetylcholine Receptors in Chromaffin Cells and Second Messenger Responses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appleman, M. M., Thompson, W.J. and Russell, J. R. (1973): In: Advances in Cyclic Nucleotide Research, Vol.3 (Eds.) P. Greengard and G.A. Robison, Raven Press, New York, pp. 65–98.

    Google Scholar 

  2. Axelrod, J. (1971): Science 173:598–606.

    Article  PubMed  Google Scholar 

  3. Castagna, M., Palmer, W.K. and Walsh, D.A. (1975): Eur. J. Pharmacol. 55:193–199.

    Google Scholar 

  4. Cheung, W. Y. (1970): Biochem. Biophys. Res. Commun. 38:533–538.

    Article  PubMed  Google Scholar 

  5. Cheung, W. Y., Ling, Y. M., Liu, Y. P. and Smoake, J. A. (1975): In: Cyclic Nucleotides in Disease. (Ed.) B. Weiss, University Park Press, Baltimore, pp. 321–350.

    Google Scholar 

  6. Chuang, D.M. and Costa, E. (1976): Molec. Pharmacol. 12:514–518.

    Google Scholar 

  7. Chuang, D.M. and Costa, E. (1974): Proc. Nat. Acad. Sci. USA 71: 4570–4574.

    Article  PubMed  Google Scholar 

  8. Chuang, D.M., Hollenbeck, R. and Costa, E. (1976): Science 193: 60–63.

    Article  PubMed  Google Scholar 

  9. Corbin, J.D., Soderling, T.R. and Park, C.R. (1973): J. Biol. Chem. 248:1813–1821.

    PubMed  Google Scholar 

  10. Costa, E., Chuang, D.M., Guidotti, A. and Uzunov, P. (1975): In: Chemical Tools in Catecholamine Research II. (Eds.) O. Almgren, A. Carlsson and J. Engel, North Holland Publ. Co., Amsterdam, pp.283–292.

    Google Scholar 

  11. Costa, E. and Guidotti, A. (1973): In: New Concepts in Neurotransmitter Regulation. (Ed.) A. J. Mandell, Plenum Press, New York, pp.135–152.

    Chapter  Google Scholar 

  12. Costa, E., Guidotti, A. and Hanbauer, I. (1975): In: Cyclic Nucleotides in Disease. (Ed.) B. Weiss, University Park Press, Baltimore, pp. 167–186.

    Google Scholar 

  13. Costa, E., Guidotti, A. and Hanbauer, I. (1975): In: Neuropsycho-pharmacology. (Eds.) J.R. Boissier, H. Hippius and P. Pichot, Excerpta Medica, Amsterdam, pp. 952–955.

    Google Scholar 

  14. Costa, E., Guidotti, A. and Hanbauer, I. (1974): Life Sci. 14:1169–1188.

    Article  PubMed  Google Scholar 

  15. Costa, E., Guidotti, A. and Kurosawa, A. (1975): In: Biological Membranes: Neurochemistry. Vol.41, (Ed.) Y. Eaoul, North Holland Publ. Co., Amsterdam, pp. 137–149.

    Google Scholar 

  16. Costa, E., Kurosawa, A. and Guidotti, A. (1976): Proc. Nat. Acad. Sci. USA 73: 10 58–1062.

    Google Scholar 

  17. Gnegy, M., Costa, E. and Uzunov, P. (1976): Proc. Nat. Acad. Sci. USA 73:352–355.

    Article  PubMed  Google Scholar 

  18. Gnegy, M., Uzunov, P. and Costa, E. (1976): Proc. Nat. Acad. Sci. USA 73:3887–3890.

    Article  PubMed  Google Scholar 

  19. Guidotti, A. and Costa, E. (1974): J. Pharmacol. Exp. Ther. 189: 665–675.

    PubMed  Google Scholar 

  20. Guidotti, A. and Costa, E. (1974): N.-S. Arch. Pharmacol. 282: 217–221.

    Article  Google Scholar 

  21. Guidotti, A., Hanbauer, I. and Costa, E. (1975): In: Advances in Cyclic Nucleotide Research. Vol.5. (Eds.) G.I. Drummond, P. Greengard and G. A. Robison, Raven Press, New York, pp. 619–639.

    Google Scholar 

  22. Guidotti, A., Kurosawa, A., Chuang, D.M. and Costa, E. (1975): Proc. Nat. Acad. Sci. USA 72:1152–1156.

    Article  PubMed  Google Scholar 

  23. Guidotti, A., Kurosawa, A. and Costa, E. (1976): N.-S. Arch. Pharmacol. 295:135–140.

    Article  Google Scholar 

  24. Guidotti, A., Mao, C. C. and Costa, E. (1974): In: Advances in Cytopharmacology. (Eds.) B. Ceccarelli, F. Clementi, and J. Meldolesi, Raven Press, New York, pp. 39–46.

    Google Scholar 

  25. Guidotti, A., Mao, C. C. and Costa, E. (1973): In: Frontiers in Catecholamine Research. (Eds.) E. Usdin and S. Snyder, Pergamon Press, Oxford, pp. 231–236.

    Google Scholar 

  26. Guidotti, A., Zivkovic, B., Pfeiffer, R. and Costa, E. (1973): N.-S. Arch. Pharmacol. 278:195–206.

    Article  Google Scholar 

  27. Hanbauer, I. and Guidotti, A. (1975): N.-S. Arch. Pharmacol. 287: 213–217.

    Article  Google Scholar 

  28. Hanbauer, I., Guidotti, A. and Costa, E. (1975): In: Neuropsychopharmacology. (Eds.) J. Boissier, H. Hippius and P. Pichot, Excerpta Medica Fdn., Amsterdam, pp. 932–941.

    Google Scholar 

  29. Joh, T.H., Geghman, C. and Reis, D. (1973): Proc. Nat. Acad. Sci. USA 70:2767–2771.

    Article  PubMed  Google Scholar 

  30. Jungmann, R. A., Lee, S. G. and DeAngelo, A.B. (1975): In: Advances in Cyclic Nucleotide Research. Vol. 5. (Eds.) G.I. Drummond, P. Greengard and G. A. Robison, Raven Press, New York, pp. 281–306.

    Google Scholar 

  31. Jungmann, R.A. and Schweppe, J.S. (1972): J. Biol. Chem. 247: 5535–5542.

    PubMed  Google Scholar 

  32. Keely, S.L. Jr., Corbin, J.D. and Park, C.R. (1975): Proc. Nat. Acad. Sci. USA 72:1501–1504.

    Article  PubMed  Google Scholar 

  33. Kurosawa, A., Guidotti, A. and Costa, E. (1976): Molec. Pharmacol. 12:420–432.

    Google Scholar 

  34. Kurosawa, A., Guidotti, A. and Costa, E. (1976): Science 193:691–693.

    Article  PubMed  Google Scholar 

  35. Mao, C. C. and Guidotti, A. (1974): Anal. Biochem. 59:63–68.

    Article  PubMed  Google Scholar 

  36. Mueller, R.A., Thoenen, H. and Axelrod, J. (1969): Molec. Pharmacol. 5:463–469.

    Google Scholar 

  37. Mueller, R.A., Thoenen, H. and Axelrod, J. (1969): Science 163: 468–469.

    Article  PubMed  Google Scholar 

  38. Otten, U. and Thoenen, H. (1976): N.-S. Arch. Pharmacol. 293: 105–108.

    Article  Google Scholar 

  39. Salem, R. and DeVellis, J. (1976): Fed. Proc. 35:296.

    Google Scholar 

  40. Takai, Y., Nishiyama, K., Yamamura, H. and Nishizuka, Y. (1975): J. Biol. Chem. 250:4690–4695.

    PubMed  Google Scholar 

  41. Thoenen, H., Mueller, R.A. and Axelrod, J. (1969): J. Pharmacol. Exp. Ther. 169:249–254.

    PubMed  Google Scholar 

  42. Thoenen, H., Otten, U. and Oesch, F. (1973): In: Frontiers in Catecholamine Research. (Eds.) E. Usdin and S. Snyder, Pergamon Press, Oxford, pp. 179–186.

    Google Scholar 

  43. Uzunov, P., Gnegy, M., Lehne, R., Revuelta, A. and Costa, E. (1976): In: Advances in Biochemical Psychopharmacology. Vol. 15. (Eds.) E. Costa, E. Giacobini and R. Paoletti, Raven Press, New York, pp. 283–302.

    Google Scholar 

  44. Uzunov, P., Revuelta, A. and Costa, E. (1975): Molec. Pharmacol. 11:506–510.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D. C., 20032, USA

    E. Costa, D. M. Chuang, A. Guidotti & R. Hollenbeck

Authors
  1. E. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. M. Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Guidotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Hollenbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California School of Medicine, Los Angeles, California, USA

    Donald J. Jenden

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Plenum Press, New York

About this chapter

Cite this chapter

Costa, E., Chuang, D.M., Guidotti, A., Hollenbeck, R. (1978). Control of Nuclear Function in Chromaffin Cells by Persistent Activation of Nicotinic Receptors. In: Jenden, D.J. (eds) Cholinergic Mechanisms and Psychopharmacology. Advances in Behavioral Biology, vol 24. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3096-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3096-7_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3098-1

  • Online ISBN: 978-1-4684-3096-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation